Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-21

Clinical Trial Update: Understanding Treatment Response With Naltrexone Among White Alcoholics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating treatment response to naltrexone among individuals with alcoholism; results completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Alcoholism | Phase 4 | Status: COMPLETED | Results posted: 2019-11-21